A loose-fit coculture of activated keratinocytes and dendritic cell-related cells for prediction of sensitizing potential

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 62, Issue 12, 2007, Pages 1419-1428

  Schreiner, M ^a   Peiser, M ^a   Briechle, D ^b   Stahlmann, R ^a   Zuberbier, T ^a   Wanner, R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TeSens   (Germany)

Author keywords

Contact allergy; Dendritic cell; In vitro assay; Keratinocyte; Sensitizing potential

Indexed keywords

4 AMINOACETANILIDE; ALLERGEN; CD86 ANTIGEN; CYTOKINE; IRRITANT AGENT; LIPOPOLYSACCHARIDE; PARAPHENYLENDIAMINE; TOLL LIKE RECEPTOR; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL MATURATION; COCULTURE; CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; IMMUNOASSAY; IN VITRO STUDY; KERATINOCYTE; LOOSE FIT COCULTURE BASED SENSITIZATION ASSAY; MONOCYTE; PREDICTION; PRIORITY JOURNAL; SENSITIZATION; XENOBIOTIC METABOLISM;

ALLERGENS; ANTIGENS, CD86; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; DERMATITIS, ALLERGIC CONTACT; FLOW CYTOMETRY; HUMANS; KERATINOCYTES; LOCAL LYMPH NODE ASSAY; MONOCYTES; PHENYLENEDIAMINES; SKIN TESTS; TRINITROBENZENESULFONIC ACID;

EID: 35748932338     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01511.x     Document Type: Article

References (36)

1. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001 56 : 813 824.
2. Kimber I, Weisenberger C. A murine local lymph node assay for the identification of contact allergens. Assay development and results of an initial validation study. Arch Toxicol 1989 63 : 274 282.
3. Basketter DA, Evans P, Fielder RJ, Gerberick GF, Dearman RJ, Kimber I. Local lymph node assay - validation, conduct and use in practice. Food Chem Toxicol 2002 40 : 593 598.
4. OECD. Guidelines for testing of chemicals. Guideline No. 429. Skin sensitization: the local lymph node assay. Paris : Organization of Economic Cooperation and Development, 2002.
5. Basketter DA, Scholes EW, Wahlkvist H, Montelius J. An evaluation of the suitability of benzocaine as a positive control skin sensitizer. Contact Dermatitis 1995 33 : 28 32.
6. Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 2006 6 : 476 483.
7. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 252.
8. Peiser M, Grützkau A, Wanner R, Kolde G. CD1a and CD1c cell sorting yields a homogeneous population of immature human Langerhans cells. J Immunol Methods 2003 279 : 41 53.
9. Ryan CA, Gerberick GF, Gildea LA, Hulette BC, Betts CJ, Cumberbatch M et al. Interactions of contact allergens with dendritic cells: opportunities and challenges for the development of novel approaches to hazard assessment. Toxicol Sci 2005 88 : 4 11.
10. Peiser M, Wanner R, Kolde G. Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking. J Leukoc Biol 2004 76 : 616 622.
11. Yoshida Y, Sakaguchi H, Ito Y, Okuda M, Suzuki H. Evaluation of the skin sensitization potential of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naive THP-1 cell line. Toxicol in Vitro 2003 17 : 221 228.
12. Azam P, Peiffer JL, Chamousset D, Tissier MH, Bonnet PA, Vian L et al. The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers. Toxicol Appl Pharmacol 2006 212 : 14 23.
13. Python F, Goebel C, Aeby P. Assessment of the U937 cell line for the detection of contact allergens. Toxicol Appl Pharmacol 2007 220 : 113 124.
14. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 1994 179 : 1109 1118.
15. Schuler G, Brang D, Romani N. Production and properties of large numbers of dendritic cells from human blood. In : Banchereau J, Schmitt D, editors. Dendritic cells in fundamental and clinical immunology, Vol. 2. New York : Plenum Press, 1995 : 43 52 F, Degwert J, Hoppe U. Phenotype and alloactivating capacity of dendritic cells generated under different culture conditions from human peripheral blood. In : Banchereau J, Schmitt D, editors. Dendritic cells in fundamental and clinical immunology, Vol. 2. New York : Plenum Press, 1995 : 355 357.
16. Chapius F, Rosenzweig M, Yagello M, Ekman M, Biberfeld P, Gluckman JC. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 1997 27 : 431 441.
17. Hulette BA, Ryan CA, Gerberick GF. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicol Appl Pharmacol 2002 182 : 226 233.
18. Straube F, Grenet O, Bruegger P, Ulrich P. Contact allergens and irritants show discrete differences in the activation of human monocyte-derived dendritic cells: consequences for in vitro detection of contact allergens. Arch Toxicol 2005 79 : 37 46.
19. Pichowski JS, Cumberbatch M, Dearman RJ, Basketter DA, Kimber I. Investigation of induced changes in interleukin 1beta mRNA expression by cultured human dendritic cells as an in vitro approach to skin sensitization testing. Toxicol In Vitro 2000 14 : 351 360.
20. Aeby P, Wyss C, Beck H, Griem P, Scheffler H, Goebel C. Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration. J Invest Dermatol 2004 122 : 1154 1164.
21. Geissmann F, Prost C, Monnet J, Dy M, Brousse N, Hermine O. Transforming growth factor b1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 1998 187 : 961 996.
22. Geissmann F, Revy P, Regnault A, Lepelletier Y, Dy M, Brousse N et al. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol 1999 162 : 4567 4575.
23. Aiba S, Manome H, Yoshino Y, Tagami H. In vitro treatment of human transforming growth factor-beta1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology 2000 101 : 68 75.
24. Vandebriel RJ, Van Och FM, Van Loveren H. In vitro assessment of sensitizing activity of low molecular weight compounds. Toxicol Appl Pharmacol 2005 2 (Suppl. 142 148.
25. Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 1981 211 : 1052 1054.
26. Limat A, Hunziker T. Use of epidermal equivalents generated from follicular outer root sheath cells in vitro and for autologous grafting of chronic wounds. Cells Tissues Organs 2002 172 : 79 85.
27. Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, Austyn JM. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990 172 : 1483 1493.
28. Facy V, Flouret V, Regnier M, Schmidt R. Langerhans cells integrated into human reconstructed epidermis respond to known sensitizers and ultraviolet exposure. J Invest Dermatol 2004 122 : 552 553.
29. Schaerli P, Willimann K, Ebert LM, Walz A, Moser B. Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity 2005 23 : 331 342.
30. Gerberick GF, Ryan CA, Kern PS, Dearman RJ, Kimber I, Patlewicz GY et al. A chemical dataset for evaluation of alternative approaches to skin-sensitization testing. Contact Dermatitis 2004 50 : 274 288.
31. Stahlmann R, Wegner M, Riecke K, Kruse M, Platzek T. Sensitising potential of four textile dyes and some of their metabolites in a modified local lymph node assay. Toxicology 2006 219 : 113 123.
32. Han YP, Tuan TL, Hughes M, Wu H, Garner WL. Transforming growth factor-beta- and tumor necrosis factor-alpha-mediated induction and proteolytic activation of MMP-9 in human skin. J Biol Chem 2001 276 : 22341 22350.
33. Gröne A. Keratinocytes and cytokines. Vet Immunol Immunopathol 2002 88 : 1 12.
34. Verhasselt V, Buelens C, Willems F, De Groote D, Haeffner-Cavaillon N, Goldman M. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J Immunol 1997 158 : 2919 2925.
35. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 2006 117 : 979 987.
36. Kühn U, Brand P, Willemsen J, Jonuleit H, Enk AH, Van Brandwijk-Petershans R et al. Induction of tyrosine phosphorylation in human MHC class II-positive antigen-presenting cells by stimulation with contact sensitizers. J Immunol 1998 160 : 667 673.